globe English arrow down
Business Unit
Excipients
Product Information

InhaLac® 240

MEGGLE - high quality crystalline lactose products, designed for DPIs.

The new Inhalac® 240 is a sieved grade with a fine median particle size of approx. 65μm, but still fair flowability characteristics (Carr Index), which makes it suitable for reservoir devices.

InhaLac® 240 expands the product line of sieved lactose grades for dry powder inhalation.

Inhalation aerosols offers the potential for needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins.  An industry standard in dry power inhalation formulation development, lactose monohydrate is used safely in DPI formulations. Using lactose as an excipient not only improves performance efficiency of the inhaler, but also facilitates powder handling during production. Effective performance of a dry powder inhaler largely depends on the carrier material used for the drug formulation.

With our highly controlled production process different high quality sieved and milled grades are obtained, providing an adequate range of particle sizes – making them behave as individual particles.

MEGGLE always at your service.
Phone: +49 (0) 8071-73-476

Shelf life / Retest:
24 months

Standard Packaging:
25 kg - Carton box with double PE-EVOH-PE Inliner
Particle size distribution
[Laser diffraction]

  • x10: 20-40 µm
  • x50: 60-70 µm
  • x90: 90-110 µm
Typical Values
  • Bulk Density [g/l]: 700
  • Tapped Density [g/l] : 880
  • Hausner factor: 1.24
  • Carrs index: 20 %
Benefits
  • Dedicated production process
  • Highly controlled powder characteristics
  • Highest microbial quality including low endotoxins
  • Retests after 24 months
Areas of Application
InhaLac® 240 as a sieved lactose is suitable for use in pulmonary and nasal drug delivery.

Request a SAMPLE!
Typical particle size distribution (PSD) ofsomething new
Brochure(s)
Specification(s)
Material safety data sheet(s)
Quality Statement(s)